Medical Devices; Hematology and Pathology Devices; Classification of Lynch Syndrome Test Systems
fda-device · Food and Drug Administration · Rule · Published 2018-02-27 · Effective 2018-02-27 · 83 FR 8355
Document
Document number
2018-03924
Federal Register citation
83 FR 8355
CFR reference
21 CFR 864
Type
Rule
Action
Final order.
Category
fda-device
Sub-agency
Food and Drug Administration
Publication date
2018-02-27
Effective date
2018-02-27
HHS docket
Docket No. FDA 2018-N-0339
Abstract
The Food and Drug Administration (FDA or we) is classifying Lynch syndrome test systems into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for the Lynch syndrome test systems' classification. We are taking this action because we have determined that classifying the device into class II (special controls) will provide a reasonable assurance of safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.